Human Papillomavirus (HPV) Infection in Pregnancy
NCT00194311 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 620
Last updated 2016-08-17
Summary
The purpose of this study is to determine if maternal infection with human papillomavirus (HPV) is associated with pregnancy complications including spontaneous preterm delivery (sPTD), severe preeclampsia (PE), and poor fetal growth.
Conditions
- Papillomavirus Infections
- Pregnancy Complications
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH - lead OTHER
Principal Investigators
-
Samuel Parry, MD · University of Pennsylvania
Eligibility
- Min Age
- 13 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-04-30
- Primary Completion
- 2007-08-31
- Completion
- 2007-08-31
Countries
- United States
Study Locations
More Related Trials
-
Screening To Obviate Preterm Birth
NCT01868308 ·Status: COMPLETED
-
Predictors of Aspirin Failure in Preeclampsia Prevention
NCT05709483 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Direct Measurements of Cervical Remodeling for Predicting Preterm Birth
NCT01175551 ·Status: COMPLETED
-
Risk Factors of Ectopic Pregnancy
NCT00194207 ·Status: COMPLETED
-
Clinical Study of Pregnant Women With COVID-19
NCT04701944 ·Status: UNKNOWN
-
Immunological and Cardiovascular Phenotyping of Oocyte-donation Pregnancies
NCT04731012 ·Status: RECRUITING
-
Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy
NCT04645004 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
NCT04705116 ·Status: RECRUITING
-
Infection and Adverse Pregnancy Outcome
NCT02673216 ·Status: UNKNOWN
-
The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
NCT06517628 ·Status: RECRUITING
-
Parvovirus B19 Infection in Pregnancy: Clinical Manifestations and Fetus/Newborn Outcome
NCT07338279 ·Status: RECRUITING
-
Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study
NCT00340899 ·Status: COMPLETED
-
Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination
NCT06968117 ·Status: COMPLETED
-
VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination
NCT05570630 ·Status: COMPLETED ·Phase: NA
-
International Registry of Coronavirus (COVID-19) Exposure in Pregnancy
NCT04366986 ·Status: COMPLETED
-
Biomarkers in Obstetrical Complications
NCT03480139 ·Status: COMPLETED
-
Antenatal COVID 19 Vaccination and Pregnancy Outcomes
NCT05401825 ·Status: UNKNOWN
-
Observational Maternal COVID-19 Vaccination Study
NCT04826640 ·Status: COMPLETED
-
First-trimester Prediction of Preeclampsia
NCT02189148 ·Status: COMPLETED
-
Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study
NCT04958304 ·Status: TERMINATED
-
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
NCT02749474 ·Status: RECRUITING
-
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
NCT05739123 ·Status: RECRUITING
-
Hydroxychloroquine in Prevention of Preeclampsia
NCT04755322 ·Status: COMPLETED ·Phase: NA
-
Platelets in Pregnancy
NCT06194643 ·Status: ACTIVE_NOT_RECRUITING
-
APOs Associated With Respiratory Viral Infections Before and During Early Pregnancy
NCT07257952 ·Status: NOT_YET_RECRUITING